362 filings
Page 10 of 19
8-K
ATXI
Avenue Therapeutics Inc
27 Aug 21
Other Events
9:18am
10-Q
2021 Q2
ATXI
Avenue Therapeutics Inc
Quarterly report
16 Aug 21
11:17am
8-K
ATXI
Avenue Therapeutics Inc
29 Jul 21
Other Events
4:01pm
8-K
ATXI
Avenue Therapeutics Inc
15 Jul 21
Other Events
12:00am
8-K
ATXI
Avenue Therapeutics Inc
14 Jun 21
Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol
9:00am
10-Q
2021 Q1
ATXI
Avenue Therapeutics Inc
Quarterly report
17 May 21
9:00am
4
ATXI
Avenue Therapeutics Inc
7 May 21
AVENUE THERAPEUTICS / Neil Herskowitz ownership change
8:02am
8-K
ATXI
Avenue Therapeutics Inc
3 May 21
Other Events
8:02am
8-K
ATXI
Avenue Therapeutics Inc
5 Apr 21
Departure of Directors or Certain Officers
4:49pm
10-K
2020 FY
ATXI
Avenue Therapeutics Inc
Annual report
31 Mar 21
8:04am
8-K
ATXI
Avenue Therapeutics Inc
1 Mar 21
Other Events
7:30am
8-K
ATXI
Avenue Therapeutics Inc
16 Feb 21
Other Events
8:30am
SC 13G/A
ATXI
Avenue Therapeutics Inc
12 Feb 21
AVENUE THERAPEUTICS / Opaleye Management ownership change
5:20pm
SC 13G
ATXI
Avenue Therapeutics Inc
10 Feb 21
AVENUE THERAPEUTICS / VANGUARD ownership change
10:39am
SC 13G
ATXI
Avenue Therapeutics Inc
8 Feb 21
AVENUE THERAPEUTICS / VANGUARD INDEX FUNDS ownership change
10:37am
8-K
ATXI
Avenue Therapeutics Inc
8 Jan 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
ATXI
Avenue Therapeutics Inc
17 Dec 20
Avenue Therapeutics Provides Regulatory Update for IV Tramadol
9:02am
8-K
ATXI
Avenue Therapeutics Inc
4 Dec 20
Departure of Directors or Certain Officers
4:16pm
10-Q
2020 Q3
ATXI
Avenue Therapeutics Inc
Quarterly report
4 Nov 20
5:09pm
8-K
ATXI
Avenue Therapeutics Inc
13 Oct 20
Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol
6:10am